期刊
EUROPEAN HEART JOURNAL
卷 40, 期 12, 页码 986-+出版社
OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/ehy798
关键词
Hypertrophic cardiomyopathy; United Kingdom; Survival; Aetiology
资金
- British Heart Foundation [FS/16/72/32270]
- Max's Foundation
- Great Ormond Street Hospital Children's Charity
- NIHR Great Ormond Street Hospital Biomedical Research Centre
Aims Understanding the spectrum of disease, symptom burden and natural history are essential for the management of children with hypertrophic cardiomyopathy (HCM). The effect of changing screening practices over time has not previously been studied. This study describes the clinical characteristics and outcomes of childhood HCM over four decades in a well-characterized United Kingdom cohort. Methods and results Six hundred and eighty-seven patients with HCM presented at a median age of 5.2years (range 0-16). Aetiology was: non-syndromic (n=433, 63%), RASopathy (n=126, 18.3%), Friedreich's ataxia (n=59, 8.6%) or inborn errors of metabolism (IEM) (n=64, 9%). In infants (n=159, 23%) underlying aetiology was more commonly a RASopathy (42% vs. 11.2%, P<0.0001) or IEM (18.9% vs. 6.4% P<0.0001). In those with familial disease, median age of presentation was higher (11years vs. 6years, P<0.0001), 141 (58%) presented <12years. Freedom from death or transplantation was 90.6% (87.9-92.7%) at 5years (1.5 per 100 patient years) with no era effect. Mortality was most frequently sudden cardiac death (SCD) (n=20, 2.9%). Children diagnosed during infancy or with an IEM had a worse prognosis (5-year survival 80.5% or 66.4%). Arrhythmic events occurred at a rate of 1.2 per 100 patient years and were more likely in non-syndromic patients (n=51, 88%). Conclusion This national study describes a heterogeneous disease whose outcomes depend on the age of presentation and aetiology. Overall mortality and SCD rates have not changed over time, but they remain higher than in adults with HCM, with events occurring in syndromic and non-syndromic patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据